Janssen

News

Janssen files Darzalex Faspro for rare disease light chain a...

Janssen has filed a new formulation of its Darzalex in the US for the rare and potentially fatal disease light chain (AL) amyloidosis.

News

Keeping up the PACE at the Scottish Medicines Consortium

After a nay from NICE, Scotland says aye to J&J’s Spravato

NHS patients with treatment-resistant depression in Scotland will be able to access Johnson & Johnson’s Spravato, a drug that has been turned down twice by NICE for patients in England.

News

Canada signs deals for J&J, Novavax COVID vaccines

The Canadian government has reached agreements in principle with J&J and Novavax to buy their coronavirus vaccine candidates.

News

NICE rejects Janssen's depression spray Spravato for second ...

NICE has rejected regular NHS funding for Janssen’s depression spray Spravato (esketamine) for a second time, although the company says it could salvage the situation by providing further d

Views & Analysis

3d illustration and concept of international logistics of agreements and international business. Networks and companies around the world

Time for a health innovation pact: rethinking the design and...

Janssen’s Anouk De Vroey on why we need to extend the public/private partnerships resulting from COVID-19 into more high-level dialogue on health innovation with governments.

Views & Analysis